Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine and endocrine disorders.

R F Spark, G Dickstein

    Annals of Internal Medicine
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Bromocriptine effectively treats hyperprolactinemia, restoring reproductive function in most patients. This dopaminergic agonist shows variable benefits for other endocrine disorders, with minimal side effects at low doses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.

    Minerva endocrinologica·2014
    Same author

    Hepatosplenic gamma/delta T-cell lymphoma masquerading as alcoholic hepatitis and methadone withdrawal.

    Case reports in gastroenterology·2011
    Same author

    Intrinsa fails to impress FDA advisory panel.

    International journal of impotence research·2005
    Same author

    The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts?

    Journal of endocrinological investigation·2003
    Same author

    [Does hypothyroidism contribute to the etiology of primary open angle glaucoma or is it just a coincidence?].

    Harefuah·2003
    Same author

    CRH test and ACTH test--what is the difference?

    The Israel Medical Association journal : IMAJ·2003
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology

    Background:

    • Bromocriptine is a dopaminergic agonist with diverse applications in endocrine disorders.
    • Hyperprolactinemia, acromegaly, and other conditions have been treated with bromocriptine.

    Purpose of the Study:

    • To review the efficacy and side effects of bromocriptine in various endocrine disorders.
    • To identify the most effective applications of bromocriptine therapy.

    Main Methods:

    • Review of existing literature on bromocriptine use in endocrine conditions.
    • Analysis of patient outcomes and reported side effects.

    Main Results:

    • Bromocriptine normalizes prolactin levels in hyperprolactinemia, restoring sexual and reproductive function in 90% of patients.

    Related Experiment Videos

  • Subjective improvement in acromegaly occurs in 75% of patients, with growth hormone normalization in 22%.
  • Variable benefits were observed in premenstrual tension, infertility, Nelson's syndrome, and Cushing's disease.

    • Conclusions:

    • Bromocriptine is most beneficial for treating male and female infertility linked to hyperprolactinemia.
    • Side effects are minimal at low doses; higher doses may cause digital vasospasm and gastrointestinal bleeding.